|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0011860,
umls-concept:C0017725,
umls-concept:C0023981,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0071097,
umls-concept:C0150097,
umls-concept:C0289313,
umls-concept:C0332307,
umls-concept:C0376674,
umls-concept:C0443199,
umls-concept:C0598783,
umls-concept:C1280500
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-7-2
|
|
pubmed:abstractText |
Postprandial metabolism is impaired in patients with type 2 diabetes (T2Dm). Two thiazolidinediones pioglitazone (PGZ) and rosiglitazone (RGZ) have similar effects on glycaemic control but differ in their effects on fasting lipids. This study investigated the effects of RGZ and PGZ on postprandial metabolism in a prospective, randomized crossover trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/CETP protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol Ester Transfer Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Metformin,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides,
http://linkedlifedata.com/resource/pubmed/chemical/pioglitazone,
http://linkedlifedata.com/resource/pubmed/chemical/rosiglitazone
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1520-7552
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
392-9
|
|
pubmed:meshHeading |
pubmed-meshheading:17211855-Blood Glucose,
pubmed-meshheading:17211855-Cholesterol,
pubmed-meshheading:17211855-Cholesterol Ester Transfer Proteins,
pubmed-meshheading:17211855-Cross-Over Studies,
pubmed-meshheading:17211855-Diabetes Mellitus, Type 2,
pubmed-meshheading:17211855-Fasting,
pubmed-meshheading:17211855-Female,
pubmed-meshheading:17211855-Hemoglobin A, Glycosylated,
pubmed-meshheading:17211855-Humans,
pubmed-meshheading:17211855-Hypoglycemic Agents,
pubmed-meshheading:17211855-Lipids,
pubmed-meshheading:17211855-Lipoproteins,
pubmed-meshheading:17211855-Male,
pubmed-meshheading:17211855-Metformin,
pubmed-meshheading:17211855-Postprandial Period,
pubmed-meshheading:17211855-Prospective Studies,
pubmed-meshheading:17211855-Thiazolidinediones,
pubmed-meshheading:17211855-Triglycerides
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.
|
|
pubmed:affiliation |
Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital of Berne, Inselspital, CH-3010 Bern, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
